TY  - JOUR
AU  - Rodriguez-Nogales, Alba
AU  - Algieri, Francesca
AU  - De Matteis, Laura
AU  - Lozano-Perez, A Abel
AU  - Garrido-Mesa, Jose
AU  - Vezza, Teresa
AU  - de la Fuente, J M
AU  - Cenis, Jose Luis
AU  - Gálvez, Julio
AU  - Rodriguez-Cabezas, Maria Elena
PY  - 2016
DO  - 10.2147/IJN.S116479
UR  - http://hdl.handle.net/10668/10629
T2  - International journal of nanomedicine
AB  - Current treatment of inflammatory bowel disease is based on the use of immunosuppressants or anti-inflammatory drugs, which are characterized by important side effects that can limit their use. Previous research has been performed by administering...
LA  - en
KW  - RGD
KW  - TNBS rat colitis
KW  - inflammatory bowel disease
KW  - nanoparticles
KW  - silk fibroin
KW  - Animals
KW  - Anti-Inflammatory Agents
KW  - Colitis
KW  - Cytokines
KW  - Disease Models, Animal
KW  - Female
KW  - Fibroins
KW  - Intestinal Mucosa
KW  - Intestines
KW  - Nanomedicine
KW  - Nanoparticles
KW  - Neutrophil Infiltration
KW  - Nitric Oxide Synthase Type II
KW  - Oligopeptides
KW  - Rats
KW  - Rats, Wistar
KW  - Trinitrobenzenesulfonic Acid
TI  - Intestinal anti-inflammatory effects of RGD-functionalized silk fibroin nanoparticles in trinitrobenzenesulfonic acid-induced experimental colitis in rats.
TY  - research article
VL  - 11
ER  -